Broadwood Partners and its affiliates issued the following letter to the Board of Directors of STAAR Surgical Company (STAA). Broadwood, which owns 27.5% of STAAR’s outstanding common shares, urges its fellow shareholders to vote on its GREEN Proxy Card “AGAINST” the proposed acquisition of STAAR by Alcon Inc. (ALC) on the terms announced on August 5, 2025.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on STAA:
- Staar Surgical says no acquisition proposals received except from Alcon
- Broadwood: Proxy advisory firms recommend Staar shareholders vote against sale
- STAAR Surgical Faces Legal Challenges in Alcon Merger
- Broadwood issues letter to Staar Surgical board questioning ‘rush’ in Alcon sale
- Staar Surgical board reiterates support of Alcon merger agreement